Relay Therapeutics shares are trading lower after Oppenheimer downgraded the stock from Outperform to Perform.
Portfolio Pulse from Benzinga Newsdesk
Relay Therapeutics shares fell after Oppenheimer downgraded the stock from Outperform to Perform.
September 10, 2024 | 2:14 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Relay Therapeutics shares are trading lower following a downgrade by Oppenheimer from Outperform to Perform.
The downgrade by a reputable analyst firm like Oppenheimer can lead to a negative sentiment among investors, causing the stock price to drop. The change from Outperform to Perform suggests a less optimistic view on the stock's future performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100